As a consequence, suppression of VEGF signalling pathway by the treatment with sunitinib in tumour-bearing mice led to pronounced upregulation of CXCL10 and CXCL11 in tumour blood vessels, accompanied by a robust increase in the infiltration of leucocytes in tumours [82]. Here, CXCL10 is linked to neoplasm.